Glaucoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Glaucoma Clinical Trials Market Report Overview
The Glaucoma clinical trial market research report provides an overview of the Glaucoma clinical trials scenario. The report provides top-line data relating to the clinical trials on Glaucoma. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Glaucoma Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Glaucoma clinical trials market are Asia-Pacific, North America, Europe, Middle East & Africa, and South & Central America, among others. Asia-Pacific dominates the market.
In a country-wise analysis, as of January 2023, the US has the highest number of Glaucoma clinical trials, followed by Japan, India, China, Italy, Germany, Spain, the UK, Canada, and Iran.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan has the highest proportion of Glaucoma to Ophthalmology clinical trials as of January 2023. However, most of the clinical trials were conducted in the US during the same period.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil has the highest proportion of Glaucoma to Ophthalmology clinical trials as of January 2023. Out of all the clinical trials conducted in the E7 countries, the majority were in India.
Glaucoma Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Glaucoma clinical trials market, download a free report sample
Glaucoma Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Glaucoma clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominated the market.
Glaucoma Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Glaucoma clinical trials market, download a free report sample
Glaucoma Clinical Trials Market - Competitive Landscape
The leading sponsors in the Glaucoma clinical trials market are Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Pfizer Inc, Viatris Inc, Merck & Co Inc, Novartis AG, Kowa Co Ltd, Bausch Health Companies Inc, and Senju Pharmaceutical Co Ltd. Out of them, Alcon Inc has conducted the highest number of Glaucoma clinical trials.
Glaucoma Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the Glaucoma clinical trials market, download a free report sample
Glaucoma Clinical Trials Market Report Overview
Key Regions | Asia-Pacific, North America, Europe, Middle East & Africa, and South & Central America |
Key Countries | The US, Japan, India, China, Italy, Germany, Spain, the UK, Canada, and Iran |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Pfizer Inc, Viatris Inc, Merck & Co Inc, Novartis AG, Kowa Co Ltd, Bausch Health Companies Inc, and Senju Pharmaceutical Co Ltd |
Segments Covered in the Report
Glaucoma Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Glaucoma Clinical Trials Country Outlook (2023)
- The US
- Japan
- India
- China
- Italy
- Germany
- Spain
- The UK
- Canada
- Iran
Glaucoma Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End point status
- The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
AbbVie Inc
Santen Pharmaceutical Co Ltd
Pfizer Inc
Viatris Inc
Merck & Co Inc
Novartis AG
Kowa Co Ltd
Bausch Health Companies Inc
Senju Pharmaceutical Co Ltd
Table of Contents
Frequently asked questions
-
Which are the key regions in the Glaucoma clinical trials market?
The key regions in the Glaucoma clinical trials market are Asia-Pacific, North America, Europe, Middle East & Africa, and South & Central America, among others.
-
Which are the key countries in the Glaucoma clinical trials market?
The key countries in the Glaucoma clinical trials market are the US, Japan, India, China, Italy, Germany, Spain, the UK, Canada, and Iran.
-
Who are the key sponsor types in the Glaucoma clinical trials market?
The key sponsor types in the Glaucoma clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Glaucoma clinical trials market?
The leading sponsors in the Glaucoma clinical trials market are Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Pfizer Inc, Viatris Inc, Merck & Co Inc, Novartis AG, Kowa Co Ltd, Bausch Health Companies Inc, and Senju Pharmaceutical Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Glaucoma reports

